Holen Sie sich die Stockscreener-App
98.14
0.08%
0.08
Handel nachbörslich:
98.14
Schlusskurs vom Vortag:
$98.06
Offen:
$98.06
24-Stunden-Volumen:
9.43M
Relative Volume:
1.22
Marktkapitalisierung:
$145.42B
Einnahmen:
$18.49B
Nettoeinkommen (Verlust:
$2.50B
KGV:
58.42
EPS:
1.68
Netto-Cashflow:
$3.49B
1W Leistung:
-0.09%
1M Leistung:
-6.63%
6M Leistung:
-4.79%
1J Leistung:
+17.53%
1-Tages-Spanne:
$96.02
$98.30
1-Wochen-Bereich:
$96.02
$98.90
52-Wochen-Spanne:
$80.64
$109.50
Boston Scientific Corp Stock (BSX) Company Profile
Firmenname
Boston Scientific Corp
Sektor
Branche
Telefon
508-683-4000
Adresse
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Vergleichen Sie BSX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BSX
Boston Scientific Corp
|
98.14 | 145.30B | 18.49B | 2.50B | 3.49B | 1.68 |
|
ABT
Abbott Laboratories
|
133.31 | 233.03B | 43.11B | 13.94B | 6.78B | 7.98 |
|
SYK
Stryker Corp
|
368.57 | 141.92B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
94.30 | 122.80B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
75.27 | 43.83B | 5.69B | 1.41B | 577.90M | 6.95 |
Boston Scientific Corp Stock (BSX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-08 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2025-06-16 | Eingeleitet | Leerink Partners | Outperform |
| 2025-04-16 | Hochstufung | Needham | Hold → Buy |
| 2025-01-10 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2024-10-18 | Herabstufung | Needham | Buy → Hold |
| 2024-05-30 | Eingeleitet | Goldman | Buy |
| 2024-02-01 | Hochstufung | Mizuho | Neutral → Buy |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-06-30 | Eingeleitet | CL King | Buy |
| 2023-05-30 | Fortgesetzt | Morgan Stanley | Overweight |
| 2023-03-29 | Eingeleitet | UBS | Buy |
| 2022-12-22 | Eingeleitet | Mizuho | Neutral |
| 2022-12-20 | Fortgesetzt | Citigroup | Buy |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-07-06 | Eingeleitet | Wolfe Research | Outperform |
| 2022-05-27 | Hochstufung | Needham | Hold → Buy |
| 2022-04-13 | Fortgesetzt | Truist | Buy |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-05-26 | Herabstufung | Needham | Buy → Hold |
| 2021-05-25 | Eingeleitet | Barclays | Overweight |
| 2021-04-15 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-09-17 | Eingeleitet | Truist | Buy |
| 2020-09-11 | Eingeleitet | Wolfe Research | Peer Perform |
| 2020-04-22 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-01 | Hochstufung | Goldman | Neutral → Buy |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2020-02-13 | Eingeleitet | Goldman | Neutral |
| 2020-02-06 | Fortgesetzt | BTIG Research | Buy |
| 2019-12-30 | Bestätigt | Cowen | Outperform |
| 2019-12-19 | Herabstufung | Needham | Strong Buy → Buy |
| 2019-09-05 | Fortgesetzt | JP Morgan | Overweight |
| 2019-09-03 | Fortgesetzt | Barclays | Overweight |
| 2019-05-13 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2018-11-28 | Eingeleitet | UBS | Buy |
| 2018-10-16 | Eingeleitet | Barclays | Overweight |
| 2018-10-02 | Bestätigt | Morgan Stanley | Overweight |
| 2018-09-07 | Bestätigt | Needham | Strong Buy |
| 2018-09-04 | Hochstufung | Jefferies | Hold → Buy |
| 2018-07-06 | Bestätigt | Needham | Strong Buy |
| 2018-06-27 | Eingeleitet | Bernstein | Outperform |
| 2018-04-26 | Bestätigt | Needham | Strong Buy |
Alle ansehen
Boston Scientific Corp Aktie (BSX) Neueste Nachrichten
November 7th Options Now Available For Boston Scientific (BSX) - Nasdaq
Piper Sandler reiterates Overweight rating on Boston Scientific stock - Investing.com
SoCalBio Investor & Partnership Conference to Feature Keynotes from SetPoint CEO Murthy Simhambhatla, PhD, and MedTech Industry Deal-Maker Ray Cohen - GlobeNewswire Inc.
Single-use Duodenoscope Market Forecasts and Competitive Strategies Report 2025-2033: Ambu and Boston Scientific Lead with Innovation and Infection-Free Solutions - Yahoo Finance
Boston Scientific stock price target reiterated at $115 by TD Cowen - Investing.com
Boston Scientific stock in focus as Stifel analyzes electrophysiology data ahead of investor day By Investing.com - Investing.com
Carr Financial Group Corp Invests $1.34 Million in Boston Scientific Corporation $BSX - MarketBeat
Atle Fund Management AB Sells 6,088 Shares of Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corporation $BSX Stock Holdings Lessened by BDF Gestion - MarketBeat
Boston Scientific gains expanded CE-mark indication for Ingevity+ pacing leads to include LBBA pacing - Cardiac Rhythm News
Johnson & Johnson, Boston Scientific to Headline MEDevice Boston 2025 Keynote Sessions - Yahoo Finance
Exchange Traded Concepts LLC Boosts Stake in Boston Scientific Corporation $BSX - MarketBeat
Assenagon Asset Management S.A. Purchases 185,821 Shares of Boston Scientific Corporation $BSX - MarketBeat
Community Trust & Investment Co. Sells 27,555 Shares of Boston Scientific Corporation $BSX - MarketBeat
Mn Services Vermogensbeheer B.V. Has $59.40 Million Stake in Boston Scientific Corporation $BSX - MarketBeat
HWG Holdings LP Has $6.46 Million Stock Holdings in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corporation $BSX Shares Sold by Financiere des Professionnels Fonds d investissement inc. - MarketBeat
Boston Scientific Corporation (BSX) Expands AI-Enhanced Heart Devices With FARAPULSE Approval - Insider Monkey
UMB Bank n.a. Boosts Stake in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corporation $BSX Holdings Boosted by Avanza Fonder AB - MarketBeat
Sowell Financial Services LLC Grows Position in Boston Scientific Corporation $BSX - MarketBeat
BTC Capital Management Inc. Takes $5.83 Million Position in Boston Scientific Corporation $BSX - MarketBeat
Czech National Bank Increases Stock Position in Boston Scientific Corporation $BSX - MarketBeat
Investors Purchase High Volume of Call Options on Boston Scientific (NYSE:BSX) - MarketBeat
Boston Scientific (NYSE:BSX) Shares Unloaded Rep. Lisa C. McClain - MarketBeat
Boston Scientific's (BSX) Buy Rating Reaffirmed at Needham & Company LLC - MarketBeat
IFM Investors Pty Ltd Purchases 19,673 Shares of Boston Scientific Corporation $BSX - MarketBeat
Channel Wealth LLC Purchases New Position in Boston Scientific Corporation $BSX - MarketBeat
Jackson Square Capital LLC Invests $6.05 Million in Boston Scientific Corporation $BSX - MarketBeat
Peak Financial Advisors LLC Invests $489,000 in Boston Scientific Corporation $BSX - MarketBeat
Kera Capital Partners Inc. Acquires New Holdings in Boston Scientific Corporation $BSX - MarketBeat
Head of Boston Scientific’s Endoscopy unit is departing - MassDevice
As biotech layoffs abound, medical device jobs are on the rise - The Business Journals
Boston Scientific Lifts Long-Term Growth Outlook Ahead Of Investor Day - Finimize
Swedbank AB Has $302.82 Million Stock Holdings in Boston Scientific Corporation $BSX - MarketBeat
Needham reiterates Buy rating on Boston Scientific stock ahead of investor day By Investing.com - Investing.com
Wesbanco Bank Inc. Takes $1.55 Million Position in Boston Scientific Corporation $BSX - MarketBeat
E. Ohman J or Asset Management AB Has $44.50 Million Stake in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corporation (BSX) Rated as a ‘Buy’ at Needham on IVL Market Opportunity - Insider Monkey
Aug Shorts: Is Boston Scientific Corporation benefiting from innovation trendsStock Surge & Stepwise Swing Trade Plans - خودرو بانک
Retail Surge: Is Boston Scientific Corporation stock a smart retirement pickJuly 2025 Trade Ideas & Growth Focused Stock Pick Reports - خودرو بانک
Longboard Asset Management LP Purchases New Holdings in Boston Scientific Corporation $BSX - MarketBeat
Why Boston Scientific (BSX) is a Top Growth Stock for the Long-Term - Yahoo Finance
Sapient Capital LLC Sells 7,568 Shares of Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corporation $BSX Shares Sold by Gateway Investment Advisers LLC - MarketBeat
Thrive Wealth Management LLC Acquires New Position in Boston Scientific Corporation $BSX - MarketBeat
Thurston Springer Miller Herd & Titak Inc. Has $2.72 Million Stock Holdings in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corporation $BSX Stock Position Raised by Neville Rodie & Shaw Inc. - MarketBeat
Jones Financial Companies Lllp Reduces Position in Boston Scientific Corporation $BSX - MarketBeat
New England Research & Management Inc. Makes New $1.13 Million Investment in Boston Scientific Corporation $BSX - MarketBeat
This Minnesota company leads all others in number of patents - Star Tribune
Finanzdaten der Boston Scientific Corp-Aktie (BSX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.71%
0.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):